Allergan ROA 2006-2018 | AGN

Current and historical return on assets (ROA) values for Allergan (AGN) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Allergan ROA for the three months ending September 30, 2018 was 5.36%.
Allergan ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2018-09-30 $2.21B $106.54B 1.98%
2018-06-30 $-1.78B $108.86B -1.55%
2018-03-31 $-2.10B $112.02B -1.77%
2017-12-31 $-4.40B $118.34B -3.60%
2017-09-30 $-7.53B $118.99B -6.03%
2017-06-30 $11.65B $124.74B 8.89%
2017-03-31 $11.87B $126.84B 8.93%
2016-12-31 $14.70B $128.99B 10.86%
2016-09-30 $14.06B $143.61B 10.27%
2016-06-30 $4.15B $132.62B 3.03%
2016-03-31 $4.40B $136.07B 3.19%
2015-12-31 $3.68B $135.58B 2.65%
2015-09-30 $3.65B $142.82B 3.08%
2015-06-30 $-2.62B $138.41B -2.73%
2015-03-31 $-2.26B $139.46B -3.33%
2014-12-31 $-1.63B $52.76B -4.22%
2014-09-30 $-1.05B $53.47B -3.36%
2014-06-30 $0.06B $25.79B 0.30%
2014-03-31 $-0.55B $22.40B -3.04%
2013-12-31 $-0.75B $22.73B -4.68%
2013-09-30 $-0.57B $13.64B -4.14%
2013-06-30 $-0.56B $13.56B -4.65%
2013-03-31 $-0.06B $14.17B -0.58%
2012-12-31 $0.10B $14.12B 1.15%
2012-09-30 $0.17B $6.57B 2.48%
2012-06-30 $0.16B $6.53B 2.36%
2012-03-31 $0.27B $6.86B 4.08%
2011-12-31 $0.26B $6.70B 4.07%
2011-09-30 $0.18B $6.36B 2.99%
2011-06-30 $0.14B $6.64B 2.36%
2011-03-31 $0.16B $5.93B 2.76%
2010-12-31 $0.19B $5.69B 3.20%
2010-09-30 $0.22B $5.85B 3.84%
2010-06-30 $0.26B $5.71B 4.85%
2010-03-31 $0.24B $5.89B 4.94%
2009-12-31 $0.22B $5.90B 5.07%
2009-09-30 $0.22B $4.03B 5.78%
2009-06-30 $0.23B $3.85B 6.18%
2009-03-31 $0.24B $3.75B 6.53%
2008-12-31 $0.24B $3.68B 6.73%
2008-09-30 $0.22B $3.55B 6.31%
2008-06-30 $0.18B $3.49B 5.31%
2008-03-31 $0.16B $3.44B 4.62%
2007-12-31 $0.14B $3.47B 4.04%
2007-09-30 $-0.39B $3.46B -10.83%
2007-06-30 $-0.39B $3.49B -11.06%
2007-03-31 $-0.44B $3.55B -12.82%
2006-12-31 $-0.45B $3.76B -13.41%
2006-09-30 $0.06B $3.20B 2.00%
2006-06-30 $0.07B $3.19B 2.18%
2006-03-31 $0.12B $3.16B 3.99%
2005-12-31 $0.14B $3.08B 4.43%
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $54.860B $15.941B
Allergan, Inc. is a healthcare company. It focuses on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, urological and other specialty markets. Allergan plc, formerly known as Actavis plc, is headquartered in Dublin, Ireland.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $23.927B 7.33
Mylan (MYL) United Kingdom $18.439B 7.59
Bausch Health Cos (BHC) Canada $9.314B 6.74
Dr Reddy's Laboratories (RDY) India $5.645B 22.54
Mallinckrodt Public Limited Company (MNK) United Kingdom $2.589B 4.32
Supernus Pharmaceuticals (SUPN) United States $2.357B 22.33
Amphastar Pharmaceuticals (AMPH) United States $0.978B 106.05
Akorn (AKRX) United States $0.853B 0.00
Homology Medicines (FIXX) United States $0.748B 0.00
Assembly Biosciences (ASMB) United States $0.570B 0.00
CymaBay Therapeutics (CBAY) United States $0.536B 0.00
Corium (CORI) United States $0.458B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.451B 0.00
Voyager Therapeutics (VYGR) United States $0.384B 0.00
Adamas Pharmaceuticals (ADMS) United States $0.315B 0.00
Teligent (TLGT) United States $0.170B 0.00
Sol-Gel Technologies (SLGL) Israel $0.135B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.095B 0.00
Aevi Genomic Medicine (GNMX) United States $0.076B 0.00
Aquinox Pharmaceuticals (AQXP) Canada $0.053B 0.00
Evoke Pharma (EVOK) United States $0.046B 0.00
Acasti Pharma (ACST) Canada $0.042B 0.00
Agile Therapeutics (AGRX) United States $0.032B 0.00
China Pharma Holdings (CPHI) China $0.016B 0.00
Pernix Therapeutics Holdings (PTX) United States $0.008B 0.00